Search by Drug Name or NDC

    NDC 65862-0249-01 Alfuzosin Hydrochloride 10 mg/1 Details

    Alfuzosin Hydrochloride 10 mg/1

    Alfuzosin Hydrochloride is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is ALFUZOSIN HYDROCHLORIDE.

    Product Information

    NDC 65862-0249
    Product ID 65862-249_d8c832c1-9455-4647-822a-ee4f35ba0560
    Associated GPIs 56852010107530
    GCN Sequence Number 045052
    GCN Sequence Number Description alfuzosin HCl TAB ER 24H 10 MG ORAL
    HIC3 Q9B
    HIC3 Description BENIGN PROSTATIC HYPERTROPHY/MICTURITION AGENTS
    GCN 92024
    HICL Sequence Number 010802
    HICL Sequence Number Description ALFUZOSIN HCL
    Brand/Generic Generic
    Proprietary Name Alfuzosin Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Alfuzosin Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name ALFUZOSIN HYDROCHLORIDE
    Labeler Name Aurobindo Pharma Limited
    Pharmaceutical Class Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA079060
    Listing Certified Through 2025-12-31

    Package

    NDC 65862-0249-01 (65862024901)

    NDC Package Code 65862-249-01
    Billing NDC 65862024901
    Package 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-249-01)
    Marketing Start Date 2012-08-30
    NDC Exclude Flag N
    Pricing Information N/A